Nkarta, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:NKTX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 501.2 M470.61 M448.31 M427.24 M404.21 M372.07 M Total liabilities 93.23 M91.8 M90.64 M89.34 M91.88 M86.21 M Total equity 407.98 M378.81 M357.67 M337.9 M312.32 M285.86 M Total liabilities & shareholders' equities 501.2 M470.61 M448.31 M427.24 M404.21 M372.07 M Total debt —————— Net debt ——————

News

NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program

Nkarta CEO Hastings sells $53,915 in NKTX stock

Nkarta (NKTX) president Nadir sells $11,693 in shares

Nkarta: Pushing Deeper Into A Discount Vs. Their Holdings, For No Real Reason (NKTX)

Stifel lowers Nkarta stock price target to $11 from $12, keeps Buy rating

Nkarta to present data on B-cell depleting therapy at rheumatology meeting

Nkarta (NKTX): Holding Its Support Steady Ahead Of First Data Readouts In 2025

Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - Nkarta (NASDAQ:NKTX)

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Alcoa (NYSE:AA), Americold Realty Trust (NYSE:COLD)

Nkarta stock rating downgraded at William Blair to Market Perform

Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights